お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はパーキンソン病市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはパーキンソン病の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のパーキンソン病市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはパーキンソン病のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にパーキンソン病市場を分類しています。本研究に含まれる主な企業は：Teva、Novartis、GSK、AbbVie、Merck、Boehringer Ingelheim、Amneal + Impax、Lundbeck、Sun Pharma、Wockhardt、UCB、Bausch Health、Acadia

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Carbidopa/Levodopa
    Dopamine Receptor Agonists
    MAO-Inhibitors

用途別の市場セグメント：
    Hospitals
    Clinics

本レポートの詳細内容
世界のパーキンソン病市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、パーキンソン病タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のパーキンソン病収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のパーキンソン病市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、パーキンソン病市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

パーキンソン病のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：パーキンソン病のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：パーキンソン病の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章パーキンソン病企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：パーキンソン病の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：パーキンソン病の主要企業の概要を提供し、製品の説明と仕様、パーキンソン病の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Parkinson's Disease Market
The global Parkinson's Disease market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Parkinson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Parkinson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Parkinson's Disease is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Parkinson's Disease include Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Parkinson's Disease is widely used in various fields, such as Hospitals and Clinics, etc. Hospitals provides greatest supports to the Parkinson's Disease industry development. In 2023, global % revenue of Parkinson's Disease went into Hospitals filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Parkinson's Disease market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Parkinson's Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Parkinson's Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Parkinson's Disease revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Parkinson's Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Parkinson's Disease revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Teva, Novartis, GSK, AbbVie, Merck, Boehringer Ingelheim, Amneal + Impax, Lundbeck and Sun Pharma, etc.

Market Segmentation
By Company
    Teva
    Novartis
    GSK
    AbbVie
    Merck
    Boehringer Ingelheim
    Amneal + Impax
    Lundbeck
    Sun Pharma
    Wockhardt
    UCB
    Bausch Health
    Acadia

Segment by Type
    Carbidopa/Levodopa
    Dopamine Receptor Agonists
    MAO-Inhibitors

Segment by Application
    Hospitals
    Clinics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Parkinson's Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson's Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Parkinson's Disease revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Parkinson's Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Carbidopa/Levodopa
    Table 3. Key Players of Dopamine Receptor Agonists
    Table 4. Key Players of MAO-Inhibitors
    Table 5. Global Parkinson's Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Parkinson's Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Parkinson's Disease Market Share by Region (2019-2024)
    Table 9. Global Parkinson's Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Parkinson's Disease Market Share by Region (2025-2030)
    Table 11. Parkinson's Disease Market Trends
    Table 12. Parkinson's Disease Market Drivers
    Table 13. Parkinson's Disease Market Challenges
    Table 14. Parkinson's Disease Market Restraints
    Table 15. Global Parkinson's Disease Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Parkinson's Disease Revenue Share by Players (2019-2024)
    Table 17. Global Top Parkinson's Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2023)
    Table 18. Global Parkinson's Disease Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Parkinson's Disease Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Parkinson's Disease, Headquarters and Area Served
    Table 21. Global Key Players of Parkinson's Disease, Product and Application
    Table 22. Global Key Players of Parkinson's Disease, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Parkinson's Disease Revenue Market Share by Type (2019-2024)
    Table 26. Global Parkinson's Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Parkinson's Disease Revenue Market Share by Type (2025-2030)
    Table 28. Global Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Parkinson's Disease Revenue Share by Application (2019-2024)
    Table 30. Global Parkinson's Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Parkinson's Disease Revenue Share by Application (2025-2030)
    Table 32. North America Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Parkinson's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Parkinson's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Parkinson's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Parkinson's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Parkinson's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Parkinson's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Parkinson's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Parkinson's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Parkinson's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Parkinson's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Parkinson's Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Parkinson's Disease Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Parkinson's Disease Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Parkinson's Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Parkinson's Disease Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Teva Company Details
    Table 65. Teva Business Overview
    Table 66. Teva Parkinson's Disease Product
    Table 67. Teva Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 68. Teva Recent Developments
    Table 69. Novartis Company Details
    Table 70. Novartis Business Overview
    Table 71. Novartis Parkinson's Disease Product
    Table 72. Novartis Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 73. Novartis Recent Developments
    Table 74. GSK Company Details
    Table 75. GSK Business Overview
    Table 76. GSK Parkinson's Disease Product
    Table 77. GSK Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 78. GSK Recent Developments
    Table 79. AbbVie Company Details
    Table 80. AbbVie Business Overview
    Table 81. AbbVie Parkinson's Disease Product
    Table 82. AbbVie Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 83. AbbVie Recent Developments
    Table 84. Merck Company Details
    Table 85. Merck Business Overview
    Table 86. Merck Parkinson's Disease Product
    Table 87. Merck Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 88. Merck Recent Developments
    Table 89. Boehringer Ingelheim Company Details
    Table 90. Boehringer Ingelheim Business Overview
    Table 91. Boehringer Ingelheim Parkinson's Disease Product
    Table 92. Boehringer Ingelheim Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 93. Boehringer Ingelheim Recent Developments
    Table 94. Amneal + Impax Company Details
    Table 95. Amneal + Impax Business Overview
    Table 96. Amneal + Impax Parkinson's Disease Product
    Table 97. Amneal + Impax Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 98. Amneal + Impax Recent Developments
    Table 99. Lundbeck Company Details
    Table 100. Lundbeck Business Overview
    Table 101. Lundbeck Parkinson's Disease Product
    Table 102. Lundbeck Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 103. Lundbeck Recent Developments
    Table 104. Sun Pharma Company Details
    Table 105. Sun Pharma Business Overview
    Table 106. Sun Pharma Parkinson's Disease Product
    Table 107. Sun Pharma Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 108. Sun Pharma Recent Developments
    Table 109. Wockhardt Company Details
    Table 110. Wockhardt Business Overview
    Table 111. Wockhardt Parkinson's Disease Product
    Table 112. Wockhardt Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 113. Wockhardt Recent Developments
    Table 114. UCB Company Details
    Table 115. UCB Business Overview
    Table 116. UCB Parkinson's Disease Product
    Table 117. UCB Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 118. UCB Recent Developments
    Table 119. Bausch Health Company Details
    Table 120. Bausch Health Business Overview
    Table 121. Bausch Health Parkinson's Disease Product
    Table 122. Bausch Health Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 123. Bausch Health Recent Developments
    Table 124. Acadia Company Details
    Table 125. Acadia Business Overview
    Table 126. Acadia Parkinson's Disease Product
    Table 127. Acadia Revenue in Parkinson's Disease Business (2019-2024) & (US$ Million)
    Table 128. Acadia Recent Developments
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Parkinson's Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Parkinson's Disease Market Share by Type: 2023 VS 2030
    Figure 3. Carbidopa/Levodopa Features
    Figure 4. Dopamine Receptor Agonists Features
    Figure 5. MAO-Inhibitors Features
    Figure 6. Global Parkinson's Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Parkinson's Disease Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Parkinson's Disease Report Years Considered
    Figure 11. Global Parkinson's Disease Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Parkinson's Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Parkinson's Disease Market Share by Region: 2023 VS 2030
    Figure 14. Global Parkinson's Disease Market Share by Players in 2023
    Figure 15. Global Top Parkinson's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Parkinson's Disease Revenue in 2023
    Figure 17. North America Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Parkinson's Disease Market Share by Type (2019-2030)
    Figure 19. North America Parkinson's Disease Market Share by Application (2019-2030)
    Figure 20. North America Parkinson's Disease Market Share by Country (2019-2030)
    Figure 21. United States Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Parkinson's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Parkinson's Disease Market Share by Type (2019-2030)
    Figure 25. Europe Parkinson's Disease Market Share by Application (2019-2030)
    Figure 26. Europe Parkinson's Disease Market Share by Country (2019-2030)
    Figure 27. Germany Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Parkinson's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Parkinson's Disease Market Share by Type (2019-2030)
    Figure 35. China Parkinson's Disease Market Share by Application (2019-2030)
    Figure 36. Asia Parkinson's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Parkinson's Disease Market Share by Type (2019-2030)
    Figure 38. Asia Parkinson's Disease Market Share by Application (2019-2030)
    Figure 39. Asia Parkinson's Disease Market Share by Region (2019-2030)
    Figure 40. Japan Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Parkinson's Disease Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Parkinson's Disease Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Parkinson's Disease Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Parkinson's Disease Market Share by Country (2019-2030)
    Figure 50. Brazil Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Parkinson's Disease Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Teva Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 57. Novartis Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 58. GSK Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 59. AbbVie Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 60. Merck Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 62. Amneal + Impax Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 63. Lundbeck Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 64. Sun Pharma Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 65. Wockhardt Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 66. UCB Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 67. Bausch Health Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 68. Acadia Revenue Growth Rate in Parkinson's Disease Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed